Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-12

Clinical Trial Update: Letrozole as a Prophylaxis From GTN for Complete Mole Patients [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on using letrozole as prophylaxis for GTN in patients with complete mole disease, spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Letrozole (letrozole)

Snippet

Sponsor: Zagazig University | Conditions: Gestational Trophoblastic Disease | Phase 2, Phase 3 | Status: UNKNOWN